Yes,I have saved that article .It will be great to reflect on when we see exponential growth and revenue kick in. Great buying at these levels given the expectations for the near future! IMO
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%